For Your Kitchen
Cookbooks

Everyday recipes with room for flavor, variety, and real life. Dinner should not feel like homework.

Taste it

Sponsorship complete. Dine on...

Nutrition, wellness, weight loss, and calmer healthy living.

CKM Syndrome: A New Understanding of Metabolic Health Affecting 90 Percent of U.S. Adults

Jul 10, 2026
CKM Syndrome: A New Understanding of Metabolic Health Affecting 90 Percent of U.S. Adults

Susan Gilchrist, a preventive cardiologist and epidemiologist, frequently encounters patients at the University of North Carolina Cardiovascular-Kidney-Metabolic (CKM) Syndrome Clinic who are unfamiliar with CKM syndrome and uncertain about their presence in her clinic. This lack of awareness is understandable, as CKM syndrome was only recently defined in 2023 by the American Heart Association (AHA). Alarmingly, about 90 percent of U.S. adults, which aligns with the estimated prevalence of the syndrome, have never heard of it.

CKM syndrome is not a singular disease but rather a broad disorder that acknowledges the overlap among cardiovascular, kidney, and metabolic conditions, such as diabetes and obesity. Muthiah Vaduganathan, a cardiologist at Brigham and Women's Hospital, emphasizes that this syndrome reflects a modern understanding of how shared risk factors—specifically, excess weight, high blood pressure, elevated blood sugar, abnormal cholesterol levels, and diminished kidney function—can contribute to the development and progression of these diseases.

For Your Kitchen
Cookbooks
Taste it
Kitchen Scales
Taste it
Meal Prep Containers
Taste it

Sponsorship complete. Dine on...

The AHA has categorized CKM syndrome into a four-stage continuum, illustrating how symptoms and risk factors accumulate, thereby increasing the likelihood of heart events or kidney failure. Stage 1 includes individuals with excess fat tissue, defined by a body mass index (BMI) of 25 or higher, or a waist circumference exceeding 88 centimeters for women and 102 centimeters for men. This stage also encompasses those with dysfunctional fat tissue who may not exhibit a larger body size but show signs of poor glucose tolerance, such as prediabetes. Since BMI can misclassify individuals, experts recommend using it alongside other metrics to identify those at risk.

Stage 2 identifies individuals with metabolic risk factors stemming from excess fat tissue, including high triglycerides, high blood pressure, metabolic syndrome, diabetes, or chronic kidney disease. At this stage, individuals typically remain asymptomatic, and diagnosis often requires blood tests performed during routine physical exams.

Stage 3 includes individuals who have developed presymptomatic heart disease, such as atherosclerosis or heart failure, or those with very high-risk chronic kidney disease (CKD) or a greater than 20 percent chance of experiencing a heart event within the next decade, as determined by the AHA's PREVENT calculator. Diagnosis at this stage may occur when a healthcare provider orders screenings based on these risk factors.

Stage 4 encompasses individuals diagnosed with severe conditions such as stroke, heart failure, coronary heart disease, peripheral artery disease, or atrial fibrillation. This stage represents the most critical outcomes of CKM syndrome and carries a high risk of subsequent heart events.

Gilchrist uses this framework to help patients understand the significance of weight concerning health. She notes that while carrying extra weight does not directly equate to disease, it can lead to health complications. Specifically, a large waist circumference and high blood sugar indicate what Gilchrist describes as "metabolically dangerous" fat, which releases inflammatory proteins into the bloodstream and triggers the body's stress response. This reaction can elevate blood pressure and increase blood fat levels, leading to insulin resistance and further elevating blood sugar levels. Both high blood sugar and high blood pressure can damage the small blood vessels that supply the kidneys, impairing their waste filtration capabilities and contributing to a cycle of heart strain and kidney failure.

The formalization of the CKM framework in 2023, along with the establishment of physician guidelines for its identification and management set for June 2026, marks a significant step in recognizing this syndrome. The broad definition of CKM syndrome captures individuals from those who may feel well but have early metabolic risk factors to those with established heart disease. Vaduganathan clarifies that while 90 percent of Americans are affected, it does not imply that they all require treatment. Instead, the emphasis is on prevention and awareness of the risk of progression to one or more of these conditions, which can be mitigated through early lifestyle management.

Joseph highlights that many Americans fall between Stage 1 and Stage 4 due to typical lifestyle behaviors. The challenges of maintaining a healthy diet, engaging in physical activity, and obtaining sufficient sleep contribute to this issue. Additionally, about 20 percent of U.S. adults use tobacco products, which further exacerbates risk.

Environmental factors also play a crucial role in these behaviors. Individuals living in rural areas may lack access to grocery stores, while those in urban settings may face limited green spaces for physical activity. Joseph emphasizes that both environmental and lifestyle factors are critical areas for intervention.

At the early stages of CKM syndrome, treatment primarily focuses on lifestyle modifications. Evidence suggests that a Mediterranean-style diet can effectively lower blood pressure and blood sugar while reducing long-term cardiovascular risk. The AHA guidelines for CKM syndrome also recommend regular physical activity, avoiding nicotine, and ensuring quality sleep, along with behavioral weight loss programs for those with excess weight.

For individuals at higher stages, several long-established medications are recommended to address specific risk factors, such as metformin for blood sugar control, statins for high cholesterol, and angiotensin-converting enzyme (ACE) inhibitors for blood pressure management.

Experts are excited about new medications that offer broader benefits across multiple organ systems. For instance, glucagon-like peptides (GLP-1s) can aid in weight management and blood sugar control, while sodium-glucose cotransporter 2 (SGLT2) inhibitors help eliminate sugar through urination and have been shown to reduce heart failure admissions and stabilize kidney function. Nonsteroidal mineralocorticoid receptor antagonists (nsMRAs) can alleviate fluid retention in the kidneys, providing upstream benefits for heart health.

Gilchrist expresses optimism about the current era of medicine, noting that the CKM framework allows for the identification of at-risk individuals and the provision of medications that can help them avoid hospitalization and improve longevity.

For Your Kitchen
Cookbooks
Taste it
Kitchen Scales
Taste it
Meal Prep Containers
Taste it
Vegetable Prep & Salad Spinners
Taste it

Sponsorship complete. Dine on...

For Your Kitchen
Cookbooks

Everyday recipes with room for flavor, variety, and real life. Dinner should not feel like homework.

Taste it
Kitchen Scales

Kitchen scales for recipes that deserve more precision than 'that looks about right.'

Taste it
Meal Prep Containers

Give tomorrow's lunch a proper home. Containers for meals worth looking forward to.

Taste it
Vegetable Prep & Salad Spinners

Salad spinners and vegetable-prep tools for everyday salads, bowls, and side dishes. A little less kitchen setup, a little more time to enjoy the meal.

Taste it
Blenders & Smoothie Tools

Blenders for fruit, yogurt, soups, and the combinations you actually enjoy. Everyday kitchen tools, not a promise in a glass.

Taste it
Sheet Pans & Roasting Essentials

Sheet pans and roasting racks for vegetables and simple oven meals. Useful equipment for dinner without an elaborate production.

Taste it

Sponsorship complete. Dine on...

Across our publications

In Other News

Latest stories from other publications.

Explore all publications (opens in a new tab)